|Bid||24.10 x 800|
|Ask||24.40 x 1100|
|Day's Range||24.12 - 25.10|
|52 Week Range||11.22 - 53.69|
|Beta (5Y Monthly)||1.06|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov. 01, 2021 - Nov. 05, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||47.00|
A look at the shareholders of Pacific Biosciences of California, Inc. ( NASDAQ:PACB ) can tell us which group is most...
PacBio's (PACB) collaboration with ERGA will help scientists to take the first important step toward creating high-quality genetic maps of each plant and animal species in a reliable manner.
Partnership to improve biodiversity research, accelerate conservation with actionable and accurate genomic dataMENLO PARK, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, highly accurate sequencing platforms, today announced a partnership with The European Reference Genome Atlas (ERGA) consortium to support its efforts in understanding and protecting biodiversity by generatin